JP2016515620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016515620A5 JP2016515620A5 JP2016506353A JP2016506353A JP2016515620A5 JP 2016515620 A5 JP2016515620 A5 JP 2016515620A5 JP 2016506353 A JP2016506353 A JP 2016506353A JP 2016506353 A JP2016506353 A JP 2016506353A JP 2016515620 A5 JP2016515620 A5 JP 2016515620A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- group
- lys
- ala
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361807713P | 2013-04-02 | 2013-04-02 | |
| US61/807,713 | 2013-04-02 | ||
| US14/229,799 | 2014-03-28 | ||
| US14/229,799 US20140294902A1 (en) | 2013-04-02 | 2014-03-28 | Novel a4b7 peptide antagonists |
| PCT/US2014/032392 WO2014165449A1 (en) | 2013-04-02 | 2014-03-31 | NOVEL α4β7 PEPTIDE ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016515620A JP2016515620A (ja) | 2016-05-30 |
| JP2016515620A5 true JP2016515620A5 (cg-RX-API-DMAC7.html) | 2017-05-18 |
Family
ID=51621090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016506353A Pending JP2016515620A (ja) | 2013-04-02 | 2014-03-31 | 新規のα４β７ペプチド拮抗薬 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20140294902A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2981543A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016515620A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014165449A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| SI2968443T1 (sl) | 2013-03-15 | 2022-01-31 | Protagonist Therapeutics, Inc. | Analogi hepcidina in njihova uporaba |
| KR102787208B1 (ko) | 2014-05-16 | 2025-03-27 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | α4β7 인테그린 티오에테르 펩티드 길항제 |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US9809623B2 (en) | 2014-10-01 | 2017-11-07 | Protagonist Therapeutics, Inc. | α4β7 peptide monomer and dimer antagonists |
| US10301371B2 (en) | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| CA3017926C (en) | 2016-03-23 | 2023-10-10 | Protagonist Therapeutics, Inc. | Methods for synthesizing .alpha.4.beta.7 peptide antagonists |
| CN106366160B (zh) * | 2016-10-11 | 2019-06-14 | 厦门大学 | 基于二硫键精准配对构建富含二硫键多肽分子骨架的方法 |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| EP4501952A3 (en) | 2018-02-08 | 2025-04-16 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2019285831B2 (en) * | 2018-06-13 | 2023-11-16 | Revolo Biotherapeutics Limited | Novel protein with anti-inflammatory properties |
| AU2020311395A1 (en) | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3168135A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| PL4090670T3 (pl) | 2020-01-15 | 2025-07-28 | Janssen Biotech, Inc | Peptydowe inhibitory receptora interleukiny-23 i ich zastosowanie w leczeniu chorób zapalnych |
| WO2022109328A1 (en) | 2020-11-20 | 2022-05-27 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| JP2024525732A (ja) | 2021-07-14 | 2024-07-12 | ヤンセン バイオテツク，インコーポレーテツド | インターロイキン－２３受容体の脂質化ペプチド阻害剤 |
| US20230145835A1 (en) * | 2021-10-06 | 2023-05-11 | 48Hd Biopharma Inc. | Modulators of Alpha-4-beta-7 Integrin and MAdCAM |
| CN116098884B (zh) * | 2022-12-12 | 2024-04-19 | 山东大学 | 一种n-乙酰-l-酪氨酸在制备治疗炎症性肠病药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2106314A1 (en) * | 1991-04-05 | 1992-10-06 | John P. Burnier | Platelet aggregation inhibitors having high specification for gpiibiiia |
| GB9613112D0 (en) * | 1996-06-21 | 1996-08-28 | Zeneca Ltd | Chemical compounds |
| JP2001509493A (ja) * | 1997-07-11 | 2001-07-24 | インナーダイン， インコーポレイテッド | 放射送達構造体の調製およびシール化のための方法およびシステム |
| JP2002524108A (ja) * | 1998-07-28 | 2002-08-06 | インナーダイン， インコーポレイテッド | 吸収性近接照射療法および化学療法送達デバイスならびに方法 |
| WO2001068586A2 (en) * | 2000-03-14 | 2001-09-20 | Novartis Ag | α4β1 AND α4β7 INTEGRIN INHIBITORS |
| WO2002055106A2 (en) * | 2001-01-09 | 2002-07-18 | Merck Patent Gmbh | Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| DE10107707A1 (de) * | 2001-02-19 | 2002-08-29 | Wilex Biotechnology Gmbh | Antagonisten für alpha¶4¶beta¶7¶-Integrin |
| GB0610395D0 (en) * | 2006-05-25 | 2006-07-05 | Ge Healthcare Ltd | Novel imaging agents |
| US9193790B2 (en) * | 2006-12-07 | 2015-11-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of antagonists of the interaction between HIV GP120 and A4B7 integrin |
| EP2733150A1 (en) * | 2010-01-25 | 2014-05-21 | Cornell University | Aromatic-cationic peptides and uses of same |
| JP2011231085A (ja) * | 2010-04-30 | 2011-11-17 | Osaka Prefecture Univ | 環状ペプチド |
| EP2444101A1 (en) * | 2010-10-21 | 2012-04-25 | Universitätsklinikum Freiburg | Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
-
2014
- 2014-03-28 US US14/229,799 patent/US20140294902A1/en not_active Abandoned
- 2014-03-31 JP JP2016506353A patent/JP2016515620A/ja active Pending
- 2014-03-31 WO PCT/US2014/032392 patent/WO2014165449A1/en not_active Ceased
- 2014-03-31 EP EP14780207.8A patent/EP2981543A4/en not_active Withdrawn
-
2019
- 2019-02-22 US US16/282,920 patent/US20200017549A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016515620A5 (cg-RX-API-DMAC7.html) | ||
| JP2016518351A5 (cg-RX-API-DMAC7.html) | ||
| JP2015533833A5 (cg-RX-API-DMAC7.html) | ||
| JP2017522362A5 (cg-RX-API-DMAC7.html) | ||
| JP2017535527A5 (cg-RX-API-DMAC7.html) | ||
| RU2017114414A (ru) | НОВЫЕ АНТАГОНИСТЫ α4β7 НА ОСНОВЕ МОНОМЕРНЫХ И ДИМЕРНЫХ ПЕПТИДОВ | |
| AU2014228460B2 (en) | Pharmaceutical compositions | |
| JP2016515620A (ja) | 新規のα４β７ペプチド拮抗薬 | |
| JP2012067099A5 (cg-RX-API-DMAC7.html) | ||
| JP2025163134A (ja) | コンジュゲートされたヘプシジン模倣物 | |
| KR20160068951A (ko) | 글루카곤 유사체 | |
| US8748575B2 (en) | Therapeutic peptides | |
| CA2733006A1 (en) | Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal | |
| WO2011079015A1 (en) | Rgd-containing cyclic peptides | |
| KR20250043599A (ko) | α4β7 인테그린 티오에테르 펩티드 길항제 | |
| WO2018128828A1 (en) | Novel hepcidin mimetics and uses thereof | |
| US20240287153A1 (en) | Treating Inflammatory Lung Disease | |
| CA2769883A1 (en) | Use of melanocortins to treat dyslipidemia | |
| CN102482323A (zh) | 新型肽及其应用 | |
| LV10108B (en) | Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation | |
| JP2020055873A (ja) | 白血球動員をブロックするペプチドおよび使用方法 | |
| EP3096795B1 (en) | Activated neurotensin molecules and the uses thereof | |
| CA2405704C (en) | Bombesin analogs for treatment of cancer | |
| US20150174207A1 (en) | Methods for treating cancer with ghrh agonists | |
| CN101531707A (zh) | 新型抗肿瘤化合物 |